Zenith Health Care Ltd.

BSE: ZENITHHE · Pharmaceuticals · sector

₹3.10BSE close 2026-10-26

Key numbers

Market cap₹17 cr

Price₹3.10

52w high / low₹4 / ₹2

P/E19.4xSector median 27.9x

P/B2.2xSector median 2.9x

Book value₹1.4

Dividend yield–Sector median 0.48%

ROE2.2%Sector median 11.7%

ROCE3.1%Sector median 12.3%

OPM1.6%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA95.8xSector median 18.6x

Interest cover37.0x

Current ratio2.09x

Sales growth 3y-7.1%Sector median +9.6%

Profit growth 3y-60.0%Sector median +13.3%

PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹0 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 37.0x in the last 12 months.
Net loss in 2 of the last 6 quarters.
Other income was 200% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹3.10 on 2026-10-26: -24.8% from the 52-week high, +39.0% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹6.42 · low ₹2.88

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3	3	2	2	3	3
EBITDA	0	-0	0	0	-0	0
OPM %	0.9%	-4.1%	7.9%	11.3%	-17.2%	5.2%
Other income	0	0	0	0	0	0
Net profit	0	-0	0	0	-0	0
EPS (₹)	0.02	0.01	0.03	0.04	0.06	0.03
Revenue YoY					-23.6%	+8.9%
Profit YoY					-409.1%	–

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	22	13	14	11	11	11
EBITDA	0	0	0	0	-0	0
Net profit	0	0	0	0	0	0
EPS (₹)	0.06	0.01	0.04	0.01	0.01	0.16
Revenue growth		-41.3%	+10.2%	-21.7%	-7.1%	–
Profit growth		-74.2%	+150.0%	-65.0%	-85.7%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	-7.1%	–	–
Net profit	-60.1%	–	–
EPS	0.0%	–	–
Share price	–	-21.1% (2y)	-21.3%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	7	7
Borrowings	0	0
Cash & equivalents	3	0
Total assets	11	11
Fixed assets	2	1
Capital work in progress	0	0
Investments	0	0
Receivables	2	2
Inventory	2	3
Payables	1	2

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	1	-1
Cash from investing	-1	1
Cash from financing	0	-0
Capex	0	0
Free cash flow	0	-1

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	0.9%	0.1%
ROCE %	3.9%	0.3%
Debtor days	78	73
Inventory days	153	220
Payable days	91	113
Cash conversion cycle (days)	140	180
Working capital days	158	135

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
ZENITHHE	₹17 cr	19.4x	2.2x	2.2%	3.1%	1.6%	-7.1%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	ZENITHHE
BSE code	530665
ISIN	INE812B01026
Face value	₹1.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.